Get the Stockscreener App
349.24
1.71%
-6.06
After Hours:
349.24
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $349.24, with a volume of 869.09K.
It is down -1.71% in the last 24 hours and up +2.47% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.
See More
Previous Close:
$355.30
Open:
$352.78
24h Volume:
869.09K
Relative Volume:
1.60
Market Cap:
$20.78B
Revenue:
$2.91B
Net Income/Loss:
$622.64M
P/E Ratio:
33.32
EPS:
10.48
Net Cash Flow:
$620.14M
1W Performance:
+0.83%
1M Performance:
+2.47%
6M Performance:
-9.22%
1Y Performance:
+13.53%
1-Day Range:
$344.04
$356.14
1-Week Range:
$344.04
$360.88
52-Week Range:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
349.24 | 20.61B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Corporation (WAT) Announces Amendment to Credit Agreement - GuruFocus
Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality - marketscreener.com
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom - Investing.com
Waters Corp (WAT) Stock Price Up 3.88% on May 27 - GuruFocus
Waters acquires Halo Labs, expanding biological analysis portfolio - SelectScience
Waters Corporation (WAT) Announces Results of Annual Stockholders Meeting - GuruFocus
Waters Corp. acquires specialized imaging firm Halo Labs - Worcester Business Journal
Petri Dish: Thermo Fisher’s new partner; Waters buys California company - The Business Journals
Waters Corporation acquired Optofluidics, Inc. - marketscreener.com
Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio - Contract Pharma
Waters Acquires Halo Labs - marketscreener.com
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs | WAT Stock News - GuruFocus
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio - PR Newswire
Waters Co. (NYSE:WAT) Stock Position Raised by Cetera Investment Advisers - Defense World
Waters (WAT) Sees Price Target Increase Amid Market Caution | WAT Stock News - GuruFocus
Ameriprise Financial Inc. Trims Stake in Waters Co. (NYSE:WAT) - Defense World
HSBC lifts Carnival Corp. rating as it is now ‘in calmer waters’ - Investing.com Australia
Waters Co. (NYSE:WAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Waters Corp's India business boosted by rush for weight-loss drugs - MSN
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters CEO Brings Analytical Instruments Innovation to Jefferies Healthcare Conference 2025 - Stock Titan
Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics - marketscreener.com
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance - bastillepost.com
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What Makes Waters Corporation (WAT) a Lucrative Investment? - Yahoo Finance
Waters (NYSE:WAT) Stock Unloaded Rep. Robert Bresnahan, Jr. - Defense World
Leerink Partnrs Has Negative Forecast for Waters Q3 Earnings - Defense World
Q2 Earnings Estimate for Waters Issued By Leerink Partnrs - Defense World
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT St - GuruFocus
Analyst Expectations For Waters's Future - Benzinga
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT Stock News - GuruFocus
UBS Lowers Price Target for Waters (WAT) to $360 | WAT Stock New - GuruFocus
UBS Adjusts Price Target for Waters (WAT) Following Strong Quarter | WAT Stock News - GuruFocus
Analyst Boosts Price Target for Waters (WAT) Following Strong Q1 Results | WAT Stock News - GuruFocus
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Adjusts Price Target for Waters (WAT) Following Q1 Resu - GuruFocus
Datadog, Masimo, Waters - TradingView
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instrument Sales and Raised Guidance ... - Yahoo Finance
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instr - GuruFocus
Waters Corporation Reports Strong Q1 2025 Results - TipRanks
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
Waters: Q1 Earnings Snapshot - CTPost
Waters Corp Earnings Call: Strong Growth Amid Challenges - TipRanks
Waters Corporation: Still A Hold After Q1 Earnings (NYSE:WAT) - Seeking Alpha
Chevron navigates rough first quarter waters - Odessa American
Waters Earnings: Fair Value Estimate Up Amid Strong Start to 2025, Including Higher Instrument Sales - Morningstar
Waters Is Recovering Following a Post-Pandemic Reset Period - Morningstar
Waters (WAT) Exceeds Q1 Revenue Forecasts with Strong Performanc - GuruFocus
Waters Corp. (WAT) Anticipates Strong Sales Growth in Q2 2025 | - GuruFocus
Waters Corp Lifts Profit Forecast After Strong Demand In Asia And Americas - Finimize
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):